Body-Identical vs Synthetic HRT: What You Actually Need to Know

The short answer: if you have found yourself squinting at the words “body-identical”, “bioidentical”, “compounded” and “natural” and wondering whether they mean the same thing, you are not being slow. The labels overlap and are often used loosely, sometimes deliberately. Body-identical HRT means regulated, prescription hormones that are molecularly identical to the ones your own ovaries make: estradiol through a patch, gel or spray, plus micronised progesterone (Utrogestan). “Bioidentical” describes the same molecular match, but it is a marketing word rather than a medical category, and it is also used for unregulated compounded hormones mixed to order and sold privately, which most specialist bodies advise against for routine use. That is different again from older synthetic hormones, which are not exact copies of your own. Sorting out which is which is a safety question, not a semantic one.

You have probably seen the promise that certain hormones are “natural” and therefore safer, or read a thread where one woman swears by her compounded cream and another was told by her doctor to avoid exactly that. Both can be telling the truth. The confusion is real, and it is not your fault: the words got tangled up by marketing before the medical vocabulary caught up. This guide untangles them, so you can walk into an appointment knowing what to ask for and what to be cautious of.

Part of why this trips so many women up is that all three categories can, on paper, describe a hormone that is “the same as your own”. The molecule can be identical in more than one case. What separates them is everything around the molecule: how it is made, whether the dose is tested, who regulates it, and how much good research sits behind it. Once you see that the argument is about regulation and evidence rather than the hormone itself, the whole subject gets a lot clearer.

What does “body-identical” actually mean?

Body-identical means the hormone molecule is an exact structural copy of the hormone your body produces, and it comes as a regulated, licensed medicine. In practice that means estradiol (the main form of estrogen (oestrogen) your ovaries made in your fertile years) delivered through the skin as a patch, gel or spray, combined with micronised progesterone, sold in the UK and much of the world as Utrogestan.

“Regulated” is the load-bearing word here. These are pharmaceutical products, authorised by medicines regulators such as the MHRA in the UK or the FDA in the US. The Menopause Society’s 2022 hormone therapy position statement describes approved bioidentical hormones such as estradiol and micronised progesterone as regulated and monitored for purity and efficacy, and dispensed with package inserts based on randomised trials.

That matters more than it sounds. If you want the wider picture of how HRT works, our explainer on what HRT involves and who it suits is a good companion to this piece.

Bioidentical hormones are a marketing term, not a medical category

Bioidentical hormones are hormones whose molecule is an exact structural copy of one your own body produces. That is the entire literal meaning, and on its own it tells you nothing about safety or regulation. Estradiol and progesterone are both bioidentical whether they come from a licensed pharmaceutical product or a compounding pharmacy.

This is the trap. The word describes the shape of the molecule, not how it was made, tested or approved. ACOG’s 2023 clinical consensus notes that many compounding pharmacies use “bioidentical hormone” as a marketing term to imply their preparations are natural and therefore safer and more effective than approved medicines, and that evidence to support those claims is lacking. The term genuinely spans both a regulated prescription option and products that specialist bodies advise against.

When you see it on a clinic website or in a podcast ad, treat it as a prompt to ask the next question rather than as a quality stamp: is it regulated, is the dose consistent, and what evidence stands behind it?

How is body-identical HRT different from older synthetic HRT?

Older synthetic HRT uses hormones that are not exact copies of your own. The classic examples are conjugated equine estrogens (estrogen derived from pregnant mares’ urine, the “equine” in the name) and synthetic progestogens such as medroxyprogesterone acetate or norethisterone, which act like progesterone in the body but have a different molecular shape.

This distinction sits underneath a lot of the safety conversation. Much of the alarm that spread after the Women’s Health Initiative study in 2002 was based on one older synthetic combination. As The Menopause Society’s 2022 position statement points out, the WHI used one oral estrogen (conjugated equine estrogens) and one progestogen (medroxyprogesterone acetate), with limited enrolment of women under 60. NICE (NG23) states that the risk of venous thromboembolism (blood clots) is greater with oral than with transdermal (through-the-skin) HRT. On the progestogen side, NICE’s 2024 update says there is not yet enough evidence to establish whether breast cancer risk differs with micronised progesterone compared with other progestogens.

This is why the type and route of HRT matters so much, a point we go into in what the current evidence says about HRT safety. “Body-identical” is not a magic word, but it does describe a different, regulated modern option.

Body-identical, synthetic and compounded compared

The single most useful thing to hold onto is that “body-identical” and “compounded bioidentical” are not the same, even though the words look almost interchangeable. One is a regulated medicine. The other is mixed to order in a compounding pharmacy and is not regulated or tested in the same way. Here is how the three main categories line up.

The takeaway from that table is that regulated body-identical HRT and compounded “bioidentical” HRT can contain the very same type of hormone, yet sit at opposite ends of the safety and evidence spectrum, purely because of how they are made and tested.

What are compounded bioidentical hormones?

Compounded bioidentical hormone therapy (cBHT) is hormones mixed to order by a compounding pharmacy into custom creams, lozenges, troches or implanted pellets. The doses are often chosen from a saliva, blood or urine test, and the products are marketed as “natural” or uniquely tailored to you. The molecule may be identical to the regulated kind, but the product is not approved as a product and is made outside standard regulatory review.

Is compounding ever appropriate?

According to The Menopause Society’s 2022 position statement, compounding has a legitimate role in a narrow set of cases, such as a genuine allergy or intolerance to an ingredient in a licensed product, or a need for a form that is not commercially available. That is a clinician-led medical exception rather than a routine menopause option. The concern specialists raise is about compounded hormones being offered as a first choice when a regulated alternative already exists.

Is compounded bioidentical hormone therapy safe?

The honest answer is that nobody can tell you, because it has not been studied the way licensed medicines have. ACOG (2023) and The Menopause Society (2022) both conclude there is no good evidence that compounded products are safer or more effective than licensed HRT, and the core problem is not the hormone but the lack of oversight. The idea of an identical molecule is not the issue: body-identical HRT already offers that on prescription.

Doses and purity are not guaranteed

Without standard testing you cannot be sure how much active hormone is in a compounded product, or whether it is the same from one batch to the next. ACOG’s 2023 consensus cites a study of compounded estradiol and progesterone products from 13 compounding pharmacies that found variability across pharmacies and within batches. As a patient, you would have no way to know. In a small randomised pharmacokinetic trial (Sood and colleagues, Mayo Clinic, published in Maturitas in 2013), the compounded estrogen cream doses then in common use produced lower estrogen levels than a standard-dose estradiol patch.

The FDA states that compounded drugs are not FDA-approved and that it does not review their safety, effectiveness or quality before they are marketed. Licensed products go through that review. Compounded products skip it, which is why “it worked for my friend” is weaker reassurance than it sounds. One person’s experience says nothing about what is in your particular batch.

The progesterone side matters most

In anyone with a uterus, estrogen must be properly balanced with a progestogen to protect the womb lining, and an inconsistent compounded dose cannot guarantee that protection. NICE (NG23) notes that in people with a uterus, endometrial (womb) cancer risk increases with estrogen-only HRT, so if a compounded product does not deliver enough progesterone, the lining is left without that protection. Under-dosing here is not a minor inconvenience; it is the mechanism of harm.

Saliva tests do not reliably guide dosing

The “custom dosing from a saliva test” pitch deserves particular scrutiny. The Menopause Society’s 2022 position statement says salivary and urine hormone testing to determine dosing is unreliable and not recommended, citing diurnal (through-the-day) variation and differences within and between individuals. ACOG (2023) adds that salivary testing does not offer an accurate or precise assessment of hormone levels. That means the central promise of personalisation often rests on a test that cannot deliver it, and a one-off reading is a poor basis for mixing a bespoke dose.

A regulated product sidesteps this by giving you a known, consistent amount that your clinician adjusts to how you feel, not to a number on a lab slip.

Pellets cannot be adjusted or removed

Pellets raise an additional concern. ACOG’s 2023 consensus notes that, unlike a cream or pill that can easily be stopped, a pellet is not designed to be removed but to dissolve over time, and on the basis of that and the lack of safety data it recommends preparations other than pellets for delivering testosterone. The Menopause Society’s 2022 statement lists pellets among the nonstandard, untested routes used for compounded hormones.

What do The Menopause Society, ACOG, the BMS and the FDA say about bioidentical hormones?

Major bodies line up with striking consistency: use regulated, body-identical HRT where hormone therapy is appropriate, and do not use compounded bioidenticals routinely. This is one of the clearer areas of agreement in menopause medicine.

• The Menopause Society (formerly NAMS, the North American Menopause Society), in its 2022 hormone therapy position statement, says compounded bioidentical hormone therapy presents safety concerns including minimal government regulation and monitoring, overdosing and underdosing, impurities, lack of efficacy and safety data, and no label outlining risks. It finds insufficient evidence to support its overall clinical use for menopause symptoms.
• ACOG (the American College of Obstetricians and Gynecologists), in its 2023 Clinical Consensus No. 6, says compounded bioidentical hormone therapy should not be prescribed routinely when FDA-approved formulations exist, noting that these products are not tested for efficacy and safety by the FDA, so potency may be too high or too low.
• The British Menopause Society, in its consensus statement on bioidentical HRT, says prescribing of compounded bioidentical HRT is not recommended by national or international guidance, that compounded products are not evidence based for effectiveness and safety, and that regulated products should be prescribed wherever possible.
• The US Food and Drug Administration states that compounded drugs are not FDA-approved and that it does not review their safety, effectiveness or quality before they are marketed.

None of this is a verdict on whether you personally should take HRT. It is a verdict on which version is tested and backed by evidence.

Is “natural” the same as “safer”?

No. “Natural” is a marketing word, not a safety category, and it is one of the most misleading ideas in this whole area. A hormone being identical to your own, or plant-derived, tells you nothing on its own about whether the product delivering it is consistent, correctly dosed or safe for your body.

Conjugated equine estrogen is “natural” in that it comes from a living animal, yet it is an older synthetic-category HRT. Bioidentical hormones, including micronised progesterone, are plant-derived (ACOG, 2023), but what makes a licensed product trustworthy is that it is regulated and dose-tested, not its plant origin. The reassuring word to look for is not “natural” or even “bioidentical” on its own, it is “regulated” or “licensed”. When a product leans hard on the word “natural” while sidestepping the word “regulated”, that is your cue to ask more questions.

What should you actually ask a clinician for?

Ask for regulated body-identical HRT by name, if it suits you: transdermal estradiol (a patch, gel or spray) with micronised progesterone (Utrogestan) if you still have your womb. That combination pairs an identical molecule with a delivery route that NICE (NG23) says carries a lower clot risk than oral HRT. Using the precise terms signals that you know the difference between a licensed medicine and a compounded product, which tends to make the conversation sharper.

You do not need to memorise brand names, but a few plain questions cut through the confusion fast. “Is this a regulated, licensed product or is it compounded?” “Is the estrogen transdermal?” “Am I getting enough progesterone to protect my womb lining?” “How will my dose be monitored?”

You do not need a saliva test to start, and you can say so. The Menopause Society’s 2022 statement says serum hormone testing is rarely needed, so monitoring usually centres on how your symptoms respond rather than on chasing a target hormone number. If a clinic leads with expensive saliva panels and custom-compounded pellets or creams, describing them as safer because they are natural, it is fair to ask what evidence supports them, what regulated alternative exists, and why it would not work for you.

For the practical mechanics of getting a prescription, see our walkthrough on how to get an HRT prescription. At Yellow (spotyellow.com), our guides are built to help you have exactly that conversation, and our directory of menopause practitioners can point you towards clinicians who prescribe regulated HRT. None of this is a recommendation to start or avoid HRT. It is about walking in informed and leaving with a plan you understand.

Frequently Asked Questions

Is body-identical HRT the same as bioidentical HRT?

The molecules can be identical, but the terms are used differently. “Body-identical” refers to regulated, licensed hormones that match your own, like estradiol and micronised progesterone. “Bioidentical” is a looser marketing word that also covers unregulated compounded products, so the label alone does not tell you whether something is regulated. Asking for regulated body-identical HRT avoids the ambiguity.

Are bioidentical hormones safer than regular HRT?

Not inherently. “Bioidentical” describes the molecule’s shape, not its safety or regulation. Regulated body-identical HRT, which is bioidentical and licensed, is well studied. Compounded bioidentical products are also bioidentical but are not regulated or tested the same way, so no reliable safety data supports them. Which option suits you is a conversation for your clinician.

Is body-identical HRT safer than synthetic HRT?

“Safer” depends on the person and the route. NICE (NG23) says clot risk is greater with oral than transdermal HRT, but its 2024 update found not enough evidence to say whether breast cancer risk differs with micronised progesterone versus other progestogens. Your history, age and symptoms all shape what is safest for you, which is a conversation for your clinician.

Are compounded bioidentical hormones dangerous?

They are not necessarily dangerous, but they are unregulated and unpredictable, which is the concern. Doses can be inconsistent, purity is not guaranteed, and inadequate progesterone can leave the womb lining under-protected. According to ACOG, 2023, they should not be prescribed routinely when FDA-approved formulations exist.

Do I need a saliva test for hormone therapy?

No. The Menopause Society’s 2022 position statement says salivary hormone testing to guide dosing is unreliable and not recommended, partly because levels vary through the day. Regulated HRT is usually adjusted based on how your symptoms respond rather than on a saliva panel, so a clinic insisting on one before prescribing is worth questioning.

Is compounding ever appropriate?

Occasionally. Compounding has a legitimate role when someone has a genuine allergy or intolerance to an ingredient in a licensed product, or needs a form that is not commercially available. That is a narrow, clinician-led exception rather than a reason to choose compounded hormones as a routine menopause treatment when a regulated option exists.

What should I ask my doctor about body-identical HRT?

Ask whether the product is regulated or compounded, whether the estrogen is transdermal (patch, gel or spray), and whether you are getting enough progesterone to protect your womb lining if you still have one. Also ask how your dose will be monitored. These questions cut through most confusing marketing and support an informed decision.

Further Reading

• British Menopause Society. Bioidentical HRT (consensus statement). https://thebms.org.uk/publications/consensus-statements/bioidentical-hrt/
• The Menopause Society (NAMS). The 2022 Hormone Therapy Position Statement. Menopause, 2022. https://menopause.org/wp-content/uploads/professional/nams-2022-hormone-therapy-position-statement.pdf
• ACOG. Compounded Bioidentical Menopausal Hormone Therapy: Clinical Consensus No. 6, 2023. https://www.acog.org/clinical/clinical-guidance/clinical-consensus/articles/2023/11/compounded-bioidentical-menopausal-hormone-therapy
• NICE. Menopause: identification and management (NG23). https://www.nice.org.uk/guidance/ng23
• Sood R, Warndahl RA, Schroeder DR, et al. Bioidentical compounded hormones: a pharmacokinetic evaluation in a randomized clinical trial. Maturitas, 2013. https://pubmed.ncbi.nlm.nih.gov/23384975/

This article is for general information and does not constitute medical advice, and it is not a recommendation to take or avoid hormone therapy. HRT decisions depend on your personal medical history, and the type and route matter. Please discuss the options, including whether a regulated body-identical or other licensed HRT is right for you, with a qualified healthcare professional before starting, stopping or changing any treatment.